Marte Bliksøen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM Myocardial infarction (MI) remains a major cause of death and disability worldwide, despite available reperfusion therapies. Inflammatory signaling is considered nodal in defining final infarct size. Activation of the innate immune receptor toll-like receptors (TLR) 9 prior to ischemia and reperfusion (I/R) reduces infarct size, but the consequence of(More)
  • 1